Moneycontrol PRO
HomeAuthorSubhash helgaokar News

Subhash Helgaokar

Assistant Manager

Buy Alicon Castalloy; target of Rs 1111: Sharekhan

BUSINESS

Buy Alicon Castalloy; target of Rs 1111: Sharekhan

Sharekhan is bullish on Alicon Castalloy has recommended buy rating on the stock with a target price of Rs 1111 in its research report dated September 26, 2022.

Buy Vinati Organics; target of Rs 2500: Sharekhan

BUSINESS

Buy Vinati Organics; target of Rs 2500: Sharekhan

Sharekhan is bullish on Vinati Organics has recommended buy rating on the stock with a target price of Rs 2500 in its research report dated September 26, 2022.

Sell EURINR; target of : 78.40 : ICICI Direct

BUSINESS

Sell EURINR; target of : 78.40 : ICICI Direct

ICICI Direct, The Euro depreciated on Monday to a 20-year low amid weak economic data from the eurozone.

Agri Picks Report: Geojit

BUSINESS

Agri Picks Report: Geojit

According to Geojit , Mixed moves continued in NCDEX spices complex on Monday. Barring coriander other spices were down.

Buy IndusInd Bank; target of Rs 1450: Motilal Oswal

BUSINESS

Buy IndusInd Bank; target of Rs 1450: Motilal Oswal

Motilal Oswal is bullish on IndusInd Bank recommended buy rating on the stock with a target price of Rs 1450 in its research report dated September 23, 2022.

Buy Zydus Wellness; target of Rs 2140: Anand Rathi

BUSINESS

Buy Zydus Wellness; target of Rs 2140: Anand Rathi

Anand Rathi is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2140 in its research report dated September 23, 2022.

Buy CESC; target of Rs 108: Emkay Global Financial

BUSINESS

Buy CESC; target of Rs 108: Emkay Global Financial

Emkay Global Financial is bullish on CESC has recommended buy rating on the stock with a target price of Rs 108 in its research report dated September 26, 2022.

Agri Picks Report: Geojit

BUSINESS

Agri Picks Report: Geojit

According to Geojit , Mixed moves were witnessed in NCDEX spices complex on Friday. Turmeric futures plunged more than three per cent.

Sell EURINR; target of : 78.90 : ICICI Direct

BUSINESS

Sell EURINR; target of : 78.90 : ICICI Direct

ICICI Direct, The Euro depreciated by 1.40% on Friday amid weak economic data from the eurozone.

Buy Triveni Turbine; target of Rs 280: Sharekhan

BUSINESS

Buy Triveni Turbine; target of Rs 280: Sharekhan

Sharekhan is bullish on Triveni Turbine has recommended buy rating on the stock with a target price of Rs 280 in its research report dated September 23, 2022.

Buy Indian Hotels Company; target of Rs 380: Sharekhan

BUSINESS

Buy Indian Hotels Company; target of Rs 380: Sharekhan

Sharekhan is bullish on Indian Hotels Company has recommended buy rating on the stock with a target price of Rs 380 in its research report dated September 23, 2022.

Buy KEC International; target of Rs 515: Sharekhan

BUSINESS

Buy KEC International; target of Rs 515: Sharekhan

Sharekhan is bullish on KEC International has recommended buy rating on the stock with a target price of Rs 515 in its research report dated September 22, 2022.

Buy Minda Corporation; target of Rs 270: ICICI Direct

BUSINESS

Buy Minda Corporation; target of Rs 270: ICICI Direct

ICICI Direct is bullish on Minda Corporation has recommended buy rating on the stock with a target price of Rs 270 in its research report dated September 22, 2022.

Buy Mphasis; target of Rs 2323: Hem Securities

BUSINESS

Buy Mphasis; target of Rs 2323: Hem Securities

Hem Securities is bullish on Mphasis has recommended buy rating on the stock with a target price of Rs 2323 in its research report dated September 23, 2022.

Buy Rallis India; target of Rs 250: Prabhudas Lilladher

BUSINESS

Buy Rallis India; target of Rs 250: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Rallis India has recommended buy rating on the stock with a target price of Rs 250 in its research report dated September 22, 2022.

Buy Sun Pharmaceuticals Industries; target of Rs 1130: Sharekhan

BUSINESS

Buy Sun Pharmaceuticals Industries; target of Rs 1130: Sharekhan

Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1130 in its research report dated July 29, 2022.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347